iShares Biotechnology ETF (IBB)
| 122.90 Delayed Data As of 4:00pm ET |  +0.03 / +0.02%Today’s Change | 104.29 Today|||52-Week Range 177.37 | -19.47% Year-to-Date |
Investment Objective
The investment seeks to track the investment results of the ICE Biotechnology Index composed of U.S.-listed equities in the biotechnology sector. The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Latest IBB News
| Should You Invest in the SPDR S&P Biotech ETF (XBI)? Jul 05 / Zacks.com - Paid Partner Content | Should You Invest in the iShares Biotechnology ETF (IBB)? Jul 04 / Zacks.com - Paid Partner Content |
Performance
| 1 month | +4.21% | 3 years | +3.32% | |
| 3 months | -9.75% | 5 years | +3.29% | |
| 1 year | -27.04% | Since inception | +6.35% |
Data through 07/02/2022
Quote Details
| Previous close | $122.87 |
| Open day’s range | 121.97 – 124.08 |
| Net asset value (NAV) | 120.18 (07/01/2022) |
| Daily volume | 193,385 |
| Average volume (3 months) | 2,658,762 |
Data as of 4:00pm ET, 07/06/2022
Peer Comparisonvs. Health ETFs
| IBB | Category | |
|---|---|---|
| Performance 5-yr return | +3.29% | +11.31% |
| Expense Gross exp ratio | 0.45% | 1.01% |
| Risk 5 year sharpe ratio | 0.25 | 0.52 |
| Net assets | $7.5B | $1.9B |
| Average market cap | $20.0B | $43.0B |
| Average P/E | 13.4 | 22.2 |
| Dividend / Share | -- | 0.27% |
Competitors
| VHT Vanguard Health Care Index Fund ETF Shar... |
| IEHS iShares Evolved U.S. Healthcare Staples ... |
| FHLC Fidelity MSCI Health Care Index ETF |
Holdings
Top 5 SectorsPortfolio weighting
| Healthcare | 99.91% |
| Business service | 0.09% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
Top 10 HoldingsPortfolio weighting
| AMGN Amgen | 9.81% |
| GILD Gilead Sciences | 8.41% |
| REGN Regeneron Pharmaceuticals | 7.14% |
| VRTX Vertex Pharmaceuticals Inc | 7.04% |
| MRNA Moderna Inc | 5.23% |
| IQV IQVIA Holdings Inc | 4.05% |
| BNTX BioNTech SE | 3.24% |
| ILMN Illumina Inc | 3.17% |
| BIIB Biogen | 3.03% |
| MTD Mettler-Toledo International Inc | 2.99% |
